[{"command":"settings","settings":{"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"user":{"uid":0,"permissionsHash":"4237cf9810c335bfc947a433dd33ed19f0185a1a5b7c1fb977dfa245fd1f8c33"}},"merge":true},{"command":"add_js","selector":"body","data":[{"src":"\/sites\/default\/files\/js\/js_eiVI1CA4IDSmoT6tmxOyszBBvbEVDlvIPaadZM4E8Ko.js?scope=footer\u0026delta=0\u0026language=de\u0026theme=vermoegenszentrum\u0026include=eJwrq4rPSy0v1i-D0HogIj4lsSQVAIXJCjA"}]},{"command":"insert","method":"replaceWith","selector":".load-more-news-teasers","data":"\u003Carticle class=\u0022view-mode--teaser-by-title vz-news--32402 vz-news--news\u0022\u003E\n \n \n \n \u003Cdiv class=\u0022clearfix text-formatted field field--name-field-tagline field--type-text field--label-hidden field__item\u0022\u003E\u003Cp\u003EPharma\u003C\/p\u003E\n\u003C\/div\u003E\n \u003Cdiv class=\u0022entity-label\u0022\u003E\u003Ch2\u003E\u003Ca href=\u0022\/boersen-und-maerkte\/news\/roche-stellt-verabreichung-von-dmd-gentherapie-nicht-gehfaehige-patienten\u0022 hreflang=\u0022de\u0022\u003ERoche stellt Verabreichung von DMD-Gentherapie an nicht-gehf\u00e4hige Patienten ein\u003C\/a\u003E\u003C\/h2\u003E\u003C\/div\u003E\n\u003Cspan class=\u0022date-news\u0022 data-datetime=\u00222025-06-15T08:37:09\u0022 data-date-formatted=\u002215. Juni 2025\u0022\u003E15. Juni 2025\u003C\/span\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022view-mode--teaser-by-title vz-news--31523 vz-news--news\u0022\u003E\n \n \n \u003Cdiv class=\u0022entity-label\u0022\u003E\u003Ch2\u003E\u003Ca href=\u0022\/boersen-und-maerkte\/news\/roche-erhaelt-health-canada-zulassung-fuer-piasky-bei-pnh-blutkrankheit\u0022 hreflang=\u0022de\u0022\u003ERoche erh\u00e4lt Health-Canada-Zulassung f\u00fcr Piasky bei PNH-Blutkrankheit\u003C\/a\u003E\u003C\/h2\u003E\u003C\/div\u003E\n\u003Cspan class=\u0022date-news\u0022 data-datetime=\u00222025-06-11T13:32:08\u0022 data-date-formatted=\u002211. Juni 2025\u0022\u003E11. Juni 2025\u003C\/span\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022view-mode--teaser-by-title vz-news--30863 vz-news--news\u0022\u003E\n \n \n \u003Cdiv class=\u0022entity-label\u0022\u003E\u003Ch2\u003E\u003Ca href=\u0022\/boersen-und-maerkte\/news\/roche-erhaelt-swissmedic-zulassung-fuer-evrysdi-tablette\u0022 hreflang=\u0022de\u0022\u003ERoche erh\u00e4lt Swissmedic-Zulassung f\u00fcr Evrysdi-Tablette\u003C\/a\u003E\u003C\/h2\u003E\u003C\/div\u003E\n\u003Cspan class=\u0022date-news\u0022 data-datetime=\u00222025-06-10T05:14:10\u0022 data-date-formatted=\u002210. Juni 2025\u0022\u003E10. Juni 2025\u003C\/span\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022view-mode--teaser-by-title vz-news--29450 vz-news--news\u0022\u003E\n \n \n \n \u003Cdiv class=\u0022clearfix text-formatted field field--name-field-tagline field--type-text field--label-hidden field__item\u0022\u003E\u003Cp\u003EPharmaindustrie\u003C\/p\u003E\n\u003C\/div\u003E\n \u003Cdiv class=\u0022entity-label\u0022\u003E\u003Ch2\u003E\u003Ca href=\u0022\/boersen-und-maerkte\/news\/roche-erhaelt-eu-zulassung-fuer-sma-mittel-evrysdi-tablettenform\u0022 hreflang=\u0022de\u0022\u003ERoche erh\u00e4lt EU-Zulassung f\u00fcr SMA-Mittel Evrysdi\u00a0in Tablettenform\u003C\/a\u003E\u003C\/h2\u003E\u003C\/div\u003E\n\u003Cspan class=\u0022date-news\u0022 data-datetime=\u00222025-06-04T05:17:16\u0022 data-date-formatted=\u00224. Juni 2025\u0022\u003E4. Juni 2025\u003C\/span\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022view-mode--teaser-by-title vz-news--29009 vz-news--news\u0022\u003E\n \n \n \u003Cdiv class=\u0022entity-label\u0022\u003E\u003Ch2\u003E\u003Ca href=\u0022\/boersen-und-maerkte\/news\/roche-mit-positiven-phase-iii-daten-zu-tecentriq-mit-lurbinectedin\u0022 hreflang=\u0022de\u0022\u003ERoche mit positiven Phase-III-Daten zu Tecentriq mit Lurbinectedin\u003C\/a\u003E\u003C\/h2\u003E\u003C\/div\u003E\n\u003Cspan class=\u0022date-news\u0022 data-datetime=\u00222025-06-02T20:30:48\u0022 data-date-formatted=\u00222. Juni 2025\u0022\u003E2. Juni 2025\u003C\/span\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022view-mode--teaser-by-title vz-news--28610 vz-news--news\u0022\u003E\n \n \n \u003Cdiv class=\u0022entity-label\u0022\u003E\u003Ch2\u003E\u003Ca href=\u0022\/boersen-und-maerkte\/news\/roche-verbessert-mit-brustkrebs-kandidaten-itovebi-ueberlebenschancen\u0022 hreflang=\u0022de\u0022\u003ERoche verbessert mit Brustkrebs-Kandidaten Itovebi \u00dcberlebenschancen\u003C\/a\u003E\u003C\/h2\u003E\u003C\/div\u003E\n\u003Cspan class=\u0022date-news\u0022 data-datetime=\u00222025-05-31T12:12:09\u0022 data-date-formatted=\u002231. Mai 2025\u0022\u003E31. Mai 2025\u003C\/span\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022view-mode--teaser-by-title vz-news--28334 vz-news--news\u0022\u003E\n \n \n \u003Cdiv class=\u0022entity-label\u0022\u003E\u003Ch2\u003E\u003Ca href=\u0022\/boersen-und-maerkte\/news\/roche-erneut-mit-positiven-daten-zu-ms-medikament-fenebrutinib\u0022 hreflang=\u0022de\u0022\u003ERoche erneut mit positiven Daten zu MS-Medikament Fenebrutinib\u003C\/a\u003E\u003C\/h2\u003E\u003C\/div\u003E\n\u003Cspan class=\u0022date-news\u0022 data-datetime=\u00222025-05-30T05:15:10\u0022 data-date-formatted=\u002230. Mai 2025\u0022\u003E30. Mai 2025\u003C\/span\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022view-mode--teaser-by-title vz-news--27182 vz-news--news\u0022\u003E\n \n \n \n \u003Cdiv class=\u0022clearfix text-formatted field field--name-field-tagline field--type-text field--label-hidden field__item\u0022\u003E\u003Cp\u003EPharmabranche\u003C\/p\u003E\n\u003C\/div\u003E\n \u003Cdiv class=\u0022entity-label\u0022\u003E\u003Ch2\u003E\u003Ca href=\u0022\/boersen-und-maerkte\/news\/roche-will-antibiotikum-gegen-superbazillus-naechste-forschungsstufe\u0022 hreflang=\u0022de\u0022\u003ERoche will Antibiotikum gegen Superbazillus in n\u00e4chste Forschungsstufe bringen\u003C\/a\u003E\u003C\/h2\u003E\u003C\/div\u003E\n\u003Cspan class=\u0022date-news\u0022 data-datetime=\u00222025-05-26T11:00:12\u0022 data-date-formatted=\u002226. Mai 2025\u0022\u003E26. Mai 2025\u003C\/span\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022view-mode--teaser-by-title vz-news--27023 vz-news--news\u0022\u003E\n \n \n \u003Cdiv class=\u0022entity-label\u0022\u003E\u003Ch2\u003E\u003Ca href=\u0022\/boersen-und-maerkte\/news\/roche-krebsmittel-itovebi-inavolisib-erhaelt-positive-chmp-empfehlung\u0022 hreflang=\u0022de\u0022\u003ERoche-Krebsmittel Itovebi (Inavolisib) erh\u00e4lt positive CHMP-Empfehlung\u003C\/a\u003E\u003C\/h2\u003E\u003C\/div\u003E\n\u003Cspan class=\u0022date-news\u0022 data-datetime=\u00222025-05-23T11:51:09\u0022 data-date-formatted=\u002223. Mai 2025\u0022\u003E23. Mai 2025\u003C\/span\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022view-mode--teaser-by-title vz-news--26897 vz-news--news\u0022\u003E\n \n \n \u003Cdiv class=\u0022entity-label\u0022\u003E\u003Ch2\u003E\u003Ca href=\u0022\/boersen-und-maerkte\/news\/roche-und-broad-clinical-labs-kooperieren-im-bereich-saeuglings\u0022 hreflang=\u0022de\u0022\u003ERoche und Broad Clinical Labs kooperieren im Bereich S\u00e4uglings-Sequenzierung\u003C\/a\u003E\u003C\/h2\u003E\u003C\/div\u003E\n\u003Cspan class=\u0022date-news\u0022 data-datetime=\u00222025-05-23T05:47:08\u0022 data-date-formatted=\u002223. Mai 2025\u0022\u003E23. Mai 2025\u003C\/span\u003E\n\u003C\/article\u003E\n\u003Ca href=\u0022\/news\/load-more-teasers?start=14\u0026amp;isin_id=1237\u0022 class=\u0022use-ajax load-more-news-teasers\u0022\u003EMehr News anzeigen\u003C\/a\u003E","settings":null}]